Show simple item record

dc.contributor.authorMaria Dall'Era
dc.contributor.authorCaroline Gordon
dc.contributor.authorLu Wang
dc.contributor.authorW Joseph McCune
dc.contributor.authorPeter M Izmirly
dc.contributor.authorS Sam Lim
dc.contributor.authorCristina Drenkard
dc.contributor.authorCharles Helmick
dc.contributor.authorHilary Parton
dc.contributor.authorEmily C Somers
dc.contributor.authorElizabeth D Ferucci
dc.contributor.otherUniversity of California, San Francisco, California, USA
dc.contributor.otherRheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
dc.contributor.other1 Department of Neurology, General Hospital of Northern Theater Command, Shenyang, Liaoning Province, China
dc.contributor.other6 Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA
dc.contributor.otherDepartment of Medicine, Division of Rheumatology, New York University Grossman School of Medicine, New York, New York, USA
dc.contributor.other4 Department of Medicine, Emory University, Atlanta, Georgia, USA
dc.contributor.otherDepartment of Medicine, Division of Rheumatology, Emory University, Atlanta, GA, USA
dc.contributor.otherCenters for Disease Control and Prevention, Atlanta, Georgia, USA
dc.contributor.otherNew York City Department of Health and Mental Hygiene, New York, New York, USA
dc.contributor.otherUniversity of Michigan Schools of Medicine & Public Health, Ann Arbor, Michigan, USA
dc.contributor.otherDepartment of Research Services, Division of Community Health Services, Alaska Native Tribal Health Consortium, Anchorage, Alaska, USA
dc.date.accessioned2025-10-09T05:23:36Z
dc.date.available2025-10-09T05:23:36Z
dc.date.issued01-May-2021
dc.identifier.urihttps://lupus.bmj.com/content/8/1/e000614.full
dc.identifier.urihttp://digilib.fisipol.ugm.ac.id/repo/handle/15717717/40980
dc.description.abstractObjective To estimate the annual incidence rate of SLE in the USA.Methods A meta-analysis used sex/race/ethnicity-specific data spanning 2002–2009 from the Centers for Disease Control and Prevention network of four population-based state registries to estimate the incidence rates. SLE was defined as fulfilling the 1997 revised American College of Rheumatology classification criteria. Given heterogeneity across sites, a random effects model was employed. Applying sex/race/ethnicity-stratified rates, including data from the Indian Health Service registry, to the 2018 US Census population generated estimates of newly diagnosed SLE cases.Results The pooled incidence rate per 100 000 person-years was 5.1 (95% CI 4.6 to 5.6), higher in females than in males (8.7 vs 1.2), and highest among black females (15.9), followed by Asian/Pacific Islander (7.6), Hispanic (6.8) and white (5.7) females. Male incidence was highest in black males (2.4), followed by Hispanic (0.9), white (0.8) and Asian/Pacific Islander (0.4) males. The American Indian/Alaska Native population had the second highest race-specific SLE estimates for females (10.4 per 100 000) and highest for males (3.8 per 100 000). In 2018, an estimated 14 263 persons (95% CI 11 563 to 17 735) were newly diagnosed with SLE in the USA.Conclusions A network of population-based SLE registries provided estimates of SLE incidence rates and numbers diagnosed in the USA.
dc.language.isoEN
dc.publisherBMJ Publishing Group
dc.subject.lccImmunologic diseases. Allergy
dc.titleIncidence rates of systemic lupus erythematosus in the USA: estimates from a meta-analysis of the Centers for Disease Control and Prevention national lupus registries
dc.typeArticle
dc.description.doi10.1136/lupus-2021-000614
dc.title.journalLupus Science and Medicine
dc.identifier.e-issn2053-8790
dc.identifier.oaioai:doaj.org/journal:a0f222f92dcb4f23aba6574f18c4a5b5
dc.journal.infoVolume 8, Issue 1


This item appears in the following Collection(s)

Show simple item record